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Abstract
In response to infection by fungal pathogens, the innate immune system recognises specific fungal pathogen associated
molecular patterns (PAMPs) via pattern recognition receptors including the C-type lectin dectin-1 and members of the Toll
Like Receptor (TLR) family. Stimulation of these receptors leads to the induction of both pro- and anti-inflammatory
cytokines. The protein kinases MSK1 and 2 are known to be important in limiting inflammatory cytokine production by
macrophages in response to the TLR4 agonist LPS. In this study we show that MSKs are also activated in macrophages by
the fungal derived ligand zymosan, as well as the dectin-1 specific agonists curdlan and depleted zymosan, via the ERK1/2
and p38a MAPK pathways. Furthermore, we show that MSKs regulate dectin-1 induced IL-10 production, and that this
regulation is dependent on the ability of MSKs to phosphorylate the transcription factor CREB. IL-10 secreted in response to
zymosan was able to promote STAT3 phosphorylation via an autocrine feedback loop. Consistent with the decreased IL-10
secretion in MSK1/2 knockout macrophages, these cells also had decreased STAT3 tyrosine phosphorylation relative to wild
type controls after stimulation with zymosan. We further show that the reduction in IL-10 production in the MSK1/2
macrophages results in increased secretion of IL-12p40 in response to zymosan relative to wild type controls. The
production of high levels of IL-10 but low levels of IL-12 has previously been associated with an M2b or ‘regulatory’
macrophage phenotype, which was initially described in macrophages stimulated with a combination of immune
complexes and LPS. We found that zymosan, via dectin-1 activation, also leads to the expression of SphK1 and LIGHT,
markers of a regulatory like phenotype in mouse macrophages. The expression of these makers was further reinforced by
the high level of IL-10 secreted in response to zymosan stimulation.
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Introduction
While fungal infections in healthy individuals are relatively
benign, in immuno-compromised patients they are frequently
severe and are a major cause of morbidity and mortality. This
represents an escalating problem as the number of people in these
at-risk groups is increasing due to improved treatments for
immunosuppressive diseases such as Human Immunodeficiency
Virus, increases in the numbers of organ transplant recipients, and
the use of immunosuppressive therapies for diseases such as cancer
and autoimmune disorders.
Recognition of fungal pathogens by the innate immune system
provides an initial defence against infection. Innate immune cells
detect pathogens via the interaction of specific pathogen associated
molecular patterns (PAMPs) with germline encoded pattern
recognition receptors (PRRs) [1,2,3,4,5,6]. Several groups of
PRRs have been described, including Toll-like receptors (TLRs),
NOD-like proteins, CARD-like helicases and members of the C-
type lectin family such as dectin-1. At the onset of fungal infection,
the fungal cell wall is the first structure to be seen by innate
immune cells. Several components of the fungal cell wall are
recognised, including phospholipomannan that can stimulate
TLR2 and/or 4 and b-glucans that are recognised by the C-
type lectin dectin-1 [1,7,8]. A key role for dectin-1 in the response
to some fungal infections was first demonstrated by the finding that
dectin-1 knockout mice are more susceptible to infection with
Candida albicans or Aspergillus fumigatus [9,10]. The importance of
dectin-1 in mice however appears to relate to the species and strain
of the fungal pathogen, as a 2nd dectin-1 knockout model
demonstrated decreased resistance to Pneumocystis carinii but not
Candida albicans [11]. The role of dectin-1 is not restricted to mice
as a homozygous mutation in the dectin-1 gene in humans has
been shown to result in recurrent mucocutaneous candidiasis [12]
while a Y238X polymorphism in the dectin-1 gene is associated
with an increased incidence of Candida colonization in hemato-
PLOS ONE | www.plosone.org 1 March 2013 | Volume 8 | Issue 3 | e60086
Francesca Cianfanelli  , Gordon D. Brown , J. Simon C. Arthur
3
Cianfanelli F
poietic stem cell transplant patients [13]. In addition a role for
dectin-1 has recently been found in the gut; mice lacking dectin-1
are sensitized to chemically induced colitis that correlated to an
increased prevalence of pathogenic, compared to non-pathogenic,
commensal fungi in the gut. A polymorphism in the human dectin-
1 gene has also been correlated with the development of ulcerative
colitis [14].
Zymosan, an extract from the cell wall of Saccharomyces cerevisiae,
has been much used as a mimic for fungal stimulation in the innate
immune system. Zymosan stimulates macrophages and dendritic
Figure 1. Zymosan induced MAPK activation and IL-10 production in part through dectin-1. (A) BMDMs were isolated from wild type or
dectin-1 knockout animals on a C57/Bl6 background and stimulated with 200 mg/ml zymosan for 8 h. The levels of IL-10 protein secreted into the
media were measured. (B) Wild type BMDMs were treated with 4 mM Syk Inhibitor II where indicated for 1 h before stimulation with 200 mg/ml
zymosan for 8 h. Secreted IL-10 levels were then determined. In A and B error bars represent the standard deviation of independent cultures from 4
mice per genotype. P values (Student’s t-test) of less that 0.001 are indicated by **. (C) BMDMs from wild type or dectin-1 knockout on a 129SvJ
background were stimulated for the indicated times with 200 mg/ml zymosan. The levels of phospho and total ERK1/2, phospho and total p38 and
phospho CREB/ATF1 were then determined by immunoblotting. (D) Wild type BMDMs were treated with 2 mM PD184352 or 5 mM SB203580 where
indicated for 1 h before stimulation with 200 mg/ml zymosan for 30 min. The levels of total and phospho (T581) MSK1, phospho and total ERK1/2,
phospho and total p38a and phospho CREB/ATF1 were then determined by immunoblotting. (E) Wild type or MSK1/2 double knockout BMDMs were
stimulated with 200 mg/ml zymosan for the indicated times, and protein levels determined as in (D). In addition to MSK1, the total MSK1 antibody
also picks up a non-specific band (ns) that runs at a molecular weight just below MSK1. The blots shown are representative of one (C) or three (D and
E) separate experiments.
doi:10.1371/journal.pone.0060086.g001
MSK1 and 2 Regulate IL-10 Induction by Dectin 1
PLOS ONE | www.plosone.org 2 March 2013 | Volume 8 | Issue 3 | e60086
cells via both dectin-1 and TLR2 [8,10,15,16,17,18]. TLR2 is able
to activate signalling via the recruitment of the Myd88 adaptor
protein, leading to IL-1R-associated kinase (IRAK) activation,
Lys63 linked poly-ubiquitination of Traf6 and activation of the
Tak1 complex [4,5,6,19,20,21,22]. Tak1 in turn leads to the
activation of both the NFkB and MAPK signalling cascades.
Dectin-1 is activated by complex b-glucan containing structures.
While single b-glucan molecules can bind to the C-type lectin
domain of dectin-1, this is insufficient to activate signalling by
dectin-1. Instead complex high molecular weight b-glucans are
needed to promote receptor clustering and formation of a
‘phagocytic synapse’ before signalling pathways are activated
[23]. Like TLRs, dectin-1 can activate both NFkB and MAPK
cascades, however it signals through an ITAM-like motif in its
cytoplasmic domain that recruits the tyrosine kinase Syk to
activate downstream signalling [2,24,25].
While zymosan can induce the secretion of pro-inflammatory
cytokines, it also strongly promotes the production of IL-10, a key
anti-inflammatory cytokine that plays critical roles in controlling
inflammation. Following infection, loss of IL-10 can give rise to an
increased inflammatory reaction in response to the pathogen.
While this in some circumstances may aid pathogen clearance, it
can also give rise to cytokine induced tissue damage [26,27]. The
importance of IL-10 has been further underscored by the finding
that knockout of IL-10 in mice causes inflammatory bowel disease
due to a deregulated immune response to the gut flora [26,27]. In
line with this, mutation of IL-10 or the IL-10 receptor in humans
have been correlated to a severe early onset form of colitis [28,29].
The regulation of IL-10 transcription is complex and the
importance of different promoter elements varies depending on
the cell type and stimuli [26]. In macrophages roles for several
transcription factors have been proposed in the regulation IL-10
transcription downstream of TLRs, including Sp1, CREB, NFkB
[30,31,32,33]. In addition, IL-10 induction can be sustained by an
IFNb feedback loop in macrophages [34].
Besides its role in TLR induced IL-10 production, CREB has
also been proposed to regulate IL-10 transcription downstream of
zymosan in macrophages and dendritic cells [35,36]. The classical
mechanism for CREB activation involves its phosphorylation on
Ser133, however the kinase responsible for this phosphorylation is
dependent upon the signal. For instance PKA phosphorylates
CREB downstream of cAMP while a CaMK family member is
thought to phosphorylate CREB downstream of Ca2+ signalling
[37]. Alternatively, downstream of the ERK1/2 and p38a MAPK
cascades, MSK1 and 2 are the major CREB kinases [38].
Zymosan activates both MAPK and Ca2+ signalling, and may also
Figure 2. Dectin-1 specific ligands activate MSKs. (A) BMDMs from wild type or dectin-1 knockout on a 129SvJ background were treated with
10 mg/ml of curdlan for the indicated times and the levels of phospho and total ERK1/2, phospho and total p38a and phospho CREB/ATF1
determined by immunoblotting. (B) As (A) except cells were stimulated with 200 mg/ml of depleted zymosan. (C) Where indicated, wild type BMDMs
were treated with 2 mM PD184352 or 5 mM SB203580 for 1 h. Cells were then stimulated with 10 mg/ml of curdlan for 30 min and the levels of total
and phospho (T581) MSK1, phospho ERK1/2, phospho and total p38a and phospho CREB/ATF1 determined by immunoblotting. (D) Wild type or
MSK1/2 knockout BMDMs were stimulated with 10 mg/ml of curdlan for the indicated times and the levels of the indicated proteins determined by
immunoblotting. The blots shown are representative of one (B) or two (A, C, D) separate experiments.
doi:10.1371/journal.pone.0060086.g002
MSK1 and 2 Regulate IL-10 Induction by Dectin 1
PLOS ONE | www.plosone.org 3 March 2013 | Volume 8 | Issue 3 | e60086
activate PKA via a prostaglandin mediated feedback loop [35,36].
Thus the identity of the kinase required for CREB phosphoryla-
tion by zymosan is not clear.
MSKs are nuclear protein kinases that can be activated in cells
downstream of either the ERK1/2 or p38a MAPK cascades
[39,40]. In addition to CREB, several substrates for MSKs have
been identified, including the CREB-related transcription factor
ATF1, as well as histone H3 and the p65RelA subunit of NFkB
[38,41,42,43]. Work with the TLR4 agonist LPS in macrophages
has demonstrated an important role for MSKs in the transcription
of IL-10 downstream of TLR signalling [32,44]. Knockout of both
MSK1 and 2 reduces IL-10 secretion by macrophages in response
to LPS and as a result, MSK1/2 knockout macrophages produce
elevated levels of IL-12 compared to wild type cells. Additionally
MSKs also regulate the induction of another anti-inflammatory
cytokine, IL-1ra, following LPS stimulation [45].
In this study we establish that MSK1 and 2 are activated
downstream of dectin-1 and play a major role in dectin-1
mediated IL-10 production. In addition, we find that dectin-1
can stimulate the transcription of markers of regulatory macro-
phages in part via an IL-10 dependent mechanism.
Methods
Cell culture
Bone marrow derived macrophages (BMDMs) were prepared
from mice as described [46]. Cells were maintained on bacterial
grade plates for 7 days in DMEM supplemented with 10% heat
inactivated FBS (Biosera), 2 mM L-glutamine, 100 units/ml
penicillin G, 100 mg/ml streptomycin, 0.25 mg/ml amphotericin
(Invitrogen) and 5 ng/ml M-CSF (R&D systems). Adherent cells
were then re-plated on tissue culture grade plates in fresh media
and used 24 hours after re-plating. Bone marrow derived dendritic
cells (BMDCs) prepared from the bone marrow by differentiation
for 7 days in DMEM supplemented with 10% heat inactivated
FBS (Biosera), 2 mM L-glutamine, 100 units/ml penicillin G,
100 mg/ml streptomycin 0.25 mg/ml amphotericin (Invitrogen)
and 5 ng/ml GM-CSF (R&D systems). Where indicated, cells
were treated with 10 mM SB-747651A (kindly supplied by
GlaxoSmithKline Pharmaceuticals R&D), 2 mM PD184352,
5 mM SB203580 or 4 mM Syk Inhibitor II (Calbiochem) for
1 hour before stimulation. Selectivity data for PD 184325,
SB203580 and SB-747651A has been published previously
[47,48] while data for Syk Inhibitor II is shown in Fig S1. Cells
were stimulated with either 200 mg/ml zymosan (E. coli O26:B6,
Sigma L2654), 200 mg/ml depleted zymosan (Invivogen), 10 mg/
ml curdlan (Sigma) or 100 ng/ml LPS (Sigma) for the indicated
times. Cells were then lysed for either RNA extraction or
immunoblotting.
Gene targeted mice with deletions in IL-10, MSK1, MSK2 and
dectin-1 as well as a Ser133Ala knockin mutation in CREB have
been described previously [10,38,41,49,50]. IL-10 and MSK1/2
knockout mice had been backcrossed to C57/Bl6 mice for at least
12 generations and CREB knockin mice for 6 generations. Dectin-
1 knockouts were on either a C57/Bl6 or 129/SvJ background as
indicated in the figure legends. Mice were maintained in
accordance with UK and EU regulations, and work was covered
by an appropriate home office license (60/3923) which was subject
to review by the University of Dundee Ethical Review Committee.
Quantitative RT-PCR
RNA was isolated using the RNeasy Microkit (Qiagen). Total
RNA was reverse transcribed using iScript (BioRad), and real time
PCR carried out using Sybrgreen based detection methods.
Primers for the mRNA studies have been described previously
[34]. For each PCR primer set the PCR product from the
amplification of reverse transcribed total mRNA was cloned and
its identity confirmed by DNA sequencing. For expression analysis
18S was used as an internal control and fold induction was
determined from Ct values using the equation:
fc~E(ctuc{ctus)u =E
(ctrc{ctrs)
r
where fc is the fold change, E is the efficiency of the PCR, ct is the
threshold cycle, u is the mRNA of interest, r is the reference gene
(18s RNA), s is the sample and c is the un-stimulated control
sample.
Immunoblotting
BMDMs were lysed directly into SDS sample buffer and
aliquots run on 10% polyacrylamide gels using standard methods.
Proteins were transferred onto nitrocellulose membranes and
specific proteins detected by immunoblotting. Antibodies against
phospho-ERK1/2, phospho-p38, phospho-T581 MSK1, phos-
pho-Y705 STAT3, total ERK1/2, total p38a, total STAT3 and
Figure 3. Inhibition of MAPK pathways modulate IL-10
induction in response to zymosan. Wild type BMDMs were treated
with 2 mM PD184352 or 5 mM SB203580 as indicated. Cells were then
stimulated for a further 1 or 8 h with 200 mg/ml of zymosan. IL-10 levels
secreted into the media were measured at 8 h (A), while IL-10 mRNA
levels were determined by qPCR at 1 (B) and 8 (C) h after stimulation. IL-
10 primary transcript levels were determined by qPCR following 1 h of
stimulation. Error bars represent the standard deviation of independent
cultures from 4 mice per genotype. P values (Student’s t-test) of less
that 0.05 are indicated by * and less than 0.001 by **.
doi:10.1371/journal.pone.0060086.g003
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GAPDH were from Cell Signaling Technology. The monoclonal
antibody against phospho-Ser133 CREB was from Millipore,
while the antibody against total MSK1 has been described
previously [38].
Cytokine measurements
The amount of cytokines secreted into the cell culture media
was determined using a Luminex based technology using
multiplex reagents from Bio-Rad according to the manufacturers
protocols.
Results
Zymosan induces IL-10 secretion and MAPK activation in
BMDMs
The yeast cell wall extract zymosan is known to stimulate
macrophages via a combination of TLRs and the C-type lectin
dectin-1 [15]. Stimulation of BMDMs with zymosan strongly
stimulates secretion of IL-10 in part via stimulation of dectin-1
[10,16]. In agreement with this we found the secretion of IL-10
was significantly reduced by knockout of dectin-1 in BMDMs
(Fig 1A). Dectin-1 couples to intracellular signaling pathways via
the tyrosine kinase Syk [16]. Consistent with the dectin-1 knockout
results, in wild type cells zymosan induced IL-10 secretion was
reduced by inhibition of Syk (Fig 1B).
Dectin-1 stimulates MSK1 activation via both ERK1/2 and
p38a MAPK
Downstream of TLR4, IL-10 induction has been shown to be
regulated by the kinases MSK1 and 2, which phosphorylate the
transcription factor CREB on the IL-10 promoter [32]. We
therefore examined the possibility that dectin-1 could regulate
MSK activation. MSKs are activated following phosphorylation
by either ERK1/2 or p38a. Zymosan was able to activate both the
ERK1/2 and p38aMAPKs, as judged by dual phosphorylation of
the Thr-Xaa-Tyr motifs that correlates with the activation of these
kinases (Fig 1C). In response to zymosan, the phosphorylation of
p38a, and to a lesser extent ERK1/2, was reduced but not
abolished by knockout of dectin-1. The MSK1/2 substrate CREB
also became phosphorylated in response to zymosan and this was
reduced by the knockout of dectin-1. ATF1 is a closely related
transcription factor to CREB. The Ser133 phosphorylation site in
CREB is conserved in ATF1 and is also phosphorylated by MSKs.
ATF1 phosphorylation is detected by the phospho-CREB
antibody, and in response to zymosan its phosphorylation
mirrored that of CREB (Fig 1C). As zymosan activates both
ERK1/2 and p38a, we used small molecule inhibitors of these two
pathways to determine if one or both of these cascades were
required to activate MSK1 and phosphorylate CREB. As a
readout for MSK activation we analyzed the phosphorylation of
the MSK1 on Thr581. In cells, Thr581 can be directly
phosphorylated by ERK1/2 and/or p38a depending on the
stimuli and this is required for MSK1 activation [39,40]. ERK1/2
are activated in cells by MKK1/2. PD184352, a selective inhibitor
of MKK1/2 [47], blocked the phosphorylation and activation of
ERK1/2 in cells (Fig 1D). PD184352 also reduced, but did not
block, MSK1 and CREB phosphorylation. The p38a/b inhibitor
SB203580 had a similar effect to PD184352. A combination of
both PD184352 and SB203580 repressed MSK1 and CREB
phosphorylation more strongly than either inhibitor alone,
indicating that both ERK1/2 and p38a contribute to MSK
Figure 4. Inhibition of MAPK pathways modulates IL-10 induction in response to dectin-1 selective ligands. Wild type BMDMs were
treated with 2 mM PD184352 or 5 mM SB203580 as indicated. Cells were the stimulated with 10 mg/ml curdlan. IL-10 secretion was measured after 8 h
(A). Alternatively at 1 h IL-10 mRNA (B) or primary transcript (C) levels were determined by qPCR. (D–F) As above, except cells were stimulated with
200 mg/ml depleted zymosan. Error bars represent the standard deviation of independent cultures from 4 mice per genotype. P values (Student’s t-
test) of less than 0.05 are indicated by * and less than 0.01 by **.
doi:10.1371/journal.pone.0060086.g004
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activation downstream of zymosan (Fig 1D). While CREB is an in
vivo substrate for MSKs, it can also be phosphorylated by other
kinases, such as PKA, on the same site [37]. To confirm that
zymosan induced CREB phosphorylation via MSKs, BMDMs
from MSK1/2 knockout mice were analyzed. Double knockout of
MSK1 and 2 did not prevent ERK1/2 and p38a activation but
did abolish CREB and ATF1 phosphorylation (Fig 1E).
Zymosan induced MAPK activation is not completely abolished
by dectin-1 knockout (Fig 1C), due to the ability of zymosan to
stimulate TLRs. Therefore we also examined CREB phosphor-
ylation in response to ligands reported to be dectin-1 specific
[15,51]. Curdlan consists of purified b-glucan from Alcaligenes
faecalis. Stimulation of BMDMs with 10 mg/ml curdlan stimulated
both ERK1/2 and p38a phosphorylation, and this was abolished
by knockout of dectin-1 (Fig 2A). Depleted zymosan, a preparation
of zymosan treated with hot alkali to remove TLR2 agonists gave
similar results. For stimulation with either curdlan or depleted
zymosan, dectin-1 knockout greatly reduced the phosphorylation
of the MSK substrates CREB and ATF1 (Fig 2A–B). Similar to
what was observed for zymosan, in response to curdlan stimulation
a combined inhibition of both ERK1/2 and p38a was required in
order to block MSK1 phosphorylation on Thr581 as well as the
phosphorylation of CREB and ATF1 (Fig 2C). Analysis of MSK1/
2 knockout BMDMs again confirmed that CREB and ATF1 were
phosphorylated by MSKs downstream of curdlan, and that
MSK1/2 knockout did not block ERK1/2 or p38a activation
(Fig 2D).
Figure 5. MSKs promote IL-10 transcription. Wild type and MSK1/2 knockout BMDMs were isolated and stimulated with either 200 mg/ml of
zymosan (A, B, C), 10 mg/ml curdlan (D, E, F) or 200 mg/ml of depleted zymosan (Dep Zym, G, H, I) for the indicated times. IL-10 protein levels secreted
into the media were measured (A, D, G) and IL-10 mRNA (B, E, H) or IL-10 1u transcript (C, F, I) induction determined by qPCR. Error bars represent the
standard deviation of independent cultures from 4 mice per genotype. P values (Student’s t-test) of less than 0.05 are indicated by * and less than
0.01 by **. ns indicates a p value of more than 0.05.
doi:10.1371/journal.pone.0060086.g005
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ERK1/2 can have both positive and negative roles in
regulating IL-10 mRNA transcription
The above results indicate that dectin-1 contributes to IL-10
production in response to zymosan and that dectin-1 was able to
activate the CREB kinase MSK1. To examine the role of MAPK
signaling and MSKs in IL-10 induction we used a combination of
small molecule inhibitors and mouse knockouts. The inhibitor
PD184352 and SB203580 have been used extensively to study the
cellular roles of the ERK1/2 and p38 MAPK cascades respec-
tively. Multiple previous studies have used these compounds in
BMDMs without reported issues with toxicity (for example
[32,45,52]), and in line with this zymosan was still able to induce
TNFa mRNA in the presence of these inhibitors (Fig S2). Several
previous studies have suggested a role for ERK1/2 in zymosan
Figure 6. MSKs regulate IL-10 mRNA transcription via CREB. BMDMs were cultured from wild type, MSK1/2 knockout, CREB S133A knockin or
MSK1/2 knockout/CREB S133A knockin mice. Cells were then stimulated with 200 mg/ml zymosan for either 1 h or for the indicated times. The
induction of nur77 (A), TNFa (B) and IL-10 (C) mRNA was determined by qPCR. (D) Wild type or MSK1/2 knockout BMDMs were pretreated with 10 mM
SB-747651A for 1 h where indicated and then stimulated with zymosan for 1 h. IL-10 mRNA induction was determined by qPCR. (E) MSK1/2 knockout
BMDMs were treated with 2 mM PD184352 or 5 mM SB203580 as indicated before stimulation with zymosan for 1 h. IL-10 mRNA induction was then
determined by qPCR. Error bars represent the standard deviation of independent cultures from 4 mice per genotype. In A to C, a P value (Student’s t-
test) relative to the wild type cells of less than 0.05 is indicated by * and less than 0.01 by **. In D and E a P value of less than 0.01 relative to the no
inhibitor control is indicated by **.
doi:10.1371/journal.pone.0060086.g006
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induced IL-10 production [35,53,54]. Consistent with this we
found that pre-treatment of BMDMs with PD184352 reduced IL-
10 secretion following an 8 h treatment with zymosan. The p38a/
b inhibitor SB203580 also inhibited zymosan induced IL-10
secretion, while a combination of both PD184352 and SB203580
resulted in a greater repression of IL-10 than either inhibitor alone
(Fig 3A). Zymosan induced an increase in IL-10 mRNA levels and
this increase was still sustained 8 h after stimulation (Fig 3B–C).
When measured at 8 h, the effect of inhibiting MAPKs on IL-10
mRNA levels mirrored the effects seen on the levels of secreted IL-
10 (Fig 3C). PD184352 treatment decreased the induction IL-10
mRNA by zymosan, while SB203580 showed a trend for a
reduction in IL-10 mRNA although this did not reach statistical
significance (p,0.05). A combination of both inhibitors however
had an additive effect on IL-10 mRNA levels (Fig 3B). In contrast,
following 1 h of stimulation with zymosan the effects of inhibiting
MAPKs where different to that seen at 8 h (Fig 3C). At 1 h,
blocking ERK1/2 activation with PD184352 actually increased
rather than decreased IL-10 mRNA levels (Fig 3B). Inhibition of
p38 on its own had little effect of IL-10 mRNA levels at this time.
In combination with PD184352, SB320580 did however reduce
IL-10 mRNA levels relative to PD184352 alone (Fig 3B). While
the increase in IL-10 mRNA seen at 1 h suggests that IL-10
transcription is being activated, changes in mRNA levels could
also result from a change in mRNA turnover. Therefore the
induction of the primary transcript for IL-10 was also measured, as
this provides a better indication of the changes in transcription.
Zymosan stimulation at 1 h was able to stimulate the induction of
the primary transcript for IL-10 and the pattern of inhibition by
the MAPK inhibitors mirrored that seen for IL-10 mRNA
(Fig 3D).
To see if this effect of blocking ERK1/2 activation occurred
with dectin-1 specific ligands, the induction of IL-10 in response to
curdlan (Fig 4A–C) or depleted zymosan (Fig 4D–F) was
examined. Both curdlan and depleted zymosan were able to
induce IL-10 secretion, however the levels found in the media
were much lower than seen for zymosan (Fig 4A, D). Similar to
zymosan, a combination of both PD184352 and SB203580 was
able to reduce IL-10 secretion in response to curdlan or depleted
zymosan. Inhibition of p38 alone with SB203580 also reduced IL-
10 secretion, however not to the same extent as a combination of
both inhibitors. In contrast, PD184352 alone had little effect on
curdlan induced IL-10 secretion and caused a small increase in IL-
10 production in response to depleted zymosan (Fig 4A, D). The
induction of IL-10 mRNA by depleted zymosan or curdlan was
more transient than seen with zymosan, so the effects of MAPK
inhibition were only examined at 1 h. Similar to what was seen
with zymosan, inhibition of ERK1/2 activation with PD184352
increased the induction of IL-10 mRNA in response to a 1 h
treatment with either curdlan or depleted zymosan (Fig 4B, E). As
for zymosan, analysis of the primary transcript levels for IL-10 in
response to curdlan or depleted zymosan gave a similar pattern to
that seen for IL-10 mRNA (Fig 4C, F).
MSKs promote IL-10 transcription downstream of dectin-
1
In response to TLR stimulation, maximal IL-10 production had
been shown to be dependent on MSK activation. The above
results could suggest that dectin-1 regulation of IL-10 may not
require MSKs, as a combination of PD184352 and SB203580
blocks MSK activation (Fig 1 and 2) but not IL-10 transcription
(Fig 3 and 4). They would however also be consistent with a model
by which ERK1/2, in combination with p38a, exerted a positive
effect on IL-10 transcription via MSKs but also inhibited IL-10
transcription via 2nd mechanism independent of p38a and MSKs.
To test the involvement of MSKs we used BMDMs isolated from
MSK1/2 double knockout mice. In response to zymosan, MSK1/
2 knockout macrophages secreted less IL-10 compared to wild
type cells (Fig 5A). In line with this, the induction of IL-10 mRNA
by zymosan was also lower in MSK1/2 knockout cells and
decrease was maintained over a 12 h time course. Significantly the
decrease in IL-10 mRNA observed MSK1/2 knockouts could be
seen as early as 1 h, the time point at which PD184352 increased
IL-10 mRNA levels (Fig 5B). Analysis of the induction of the
primary transcript for IL-10 also showed a decrease in the MSK1/
2 knockout cells relative to wild type BMDMs (Fig 5C).
Similar results were also obtained when the dectin-1 specific
ligands curdlan and depleted zymosan were used (Fig 5D–I).
MSK1/2 knockout resulted in decreased IL-10 secretion in
response to curdlan and depleted zymosan (Fig 5D, G). The
induction of IL-10 mRNA in response to curdlan or depleted
zymosan was transient and was reduced by MSK1/2 knockout
(Fig 5E, H). Importantly this reduction in IL-10 mRNA levels in
the MSK1/2 knockout cells relative to wild type macrophages was
apparent following 1 h of stimulation. Similar results were also
obtained for the induction of the IL-10 primary transcript (Fig 5 F,
G). MSK1/2 knockout did not however block the induction of all
Figure 7. MSK and CREB regulate IL-10 secretion in BMDCs. (A)
BMDCs were isolated from wild type and MSK1/2 knockout mice.
Following stimulation with 200 mg/ml zymosan or 10 mg/ml curdlan for
8 h the levels of IL-10 secreted into the media was determined. (B) as
(A) except BMDCs were from wild type or CREB Ser133Ala knockin
macrophages. In both panels measurements were made for indepen-
dent preparations of BMDCs from 4 mice per genotype. Individual
measurements (open symbols) as well as average and standard
deviation are shown. A p value (Student’s t-test) of less that 0.01 is
shown by **.
doi:10.1371/journal.pone.0060086.g007
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genes as for example TNFa mRNA induction in response to
zymosan, curdlan or depleted zymosan was normal in MSK1/2
knockout BMDMs.
MSKs phosphorylate the transcription factor CREB on Ser133
and are thus able to promote the transcription of CREB
dependent genes [55]. In line with the ability of zymosan to
induce CREB phosphorylation (Fig 1), zymosan also induced the
transcription of the CREB dependent immediate early gene nur77
(Fig 6A). The transcription of nur77 was greatly decreased in cells
isolated from mice with a Ser133 to Ala knockin mutation in the
endogenous CREB gene. MSK1/2 knockout, which blocks CREB
phosphorylation, reduced nur77 mRNA induction to a similar
extent (Fig 6A). This was not due to a general impairment of
transcription as the induction of the CREB independent gene
TNFa was unaffected by either the CREB knockin or MSK1/2
knockout (Fig 6B). In agreement with the model that MSKs
regulate IL-10 transcription via the phosphorylation of CREB, the
induction of IL-10 mRNA by zymosan was lower in the CREB
knockin cells relative to wild type macrophages (Fig 6C).
Consistent with CREB acting downstream of MSKs, when crossed
onto a MSK1/2 knockout background, the CREB knockin did not
affect IL-10 mRNA levels relative to MSK1/2 knockout alone
Figure 8. Zymosan induces STAT3 phosphorylation via IL-10. (A) BMDMs were isolated from wild type or MSK1/2 knockout mice and
stimulated for the indicated times with 200 mg/ml zymosan. Cells were lysed and the levels of total and phospho (Y705) STAT3 as well as GAPDH were
determined by immunoblotting. (B, C) BMDMs from either wild type or MSK1/2 knockout mice were stimulated for the indicated times with 200 mg/
ml zymosan. Secreted IL-12p40 protein (B) and IL-12p40 mRNA (C) levels were determined. (D) Wild type, IL-10 knockout, MSK1/2 double knockout or
MSK1/2/IL-10 triple knockout BMDMs were treated with 200 mg/ml zymosan for 8 h. Secreted IL-12p40 levels were then determined. The average for
each genotype is shown by a bar and the BMDMs from individual mice by X. Error bars (B–D) represent the standard deviation of independent
cultures from 4 mice per genotype. P values (Student’s t-test) of less than 0.05 are indicated by * and less than 0.01 by **.
doi:10.1371/journal.pone.0060086.g008
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(Fig 6C). The MSK1/2 double knockout cells showed a slightly
greater reduction in IL-10 mRNA levels relative to the single
CREB mutation, suggesting that MSKs may regulate IL-10 via
both a CREB dependent and independent mechanism (Fig 6C).
This could reflect compensation from ATF1 in the CREB
Ser133Ala knockin, or a role for another MSK substrate, such
as histone H3, in IL-10 transcription.
To confirm that changes in IL-10 induction in the MSK1/2
knockout or CREB knockin BMDMs was not due to a
developmental issue in the knockout macrophages, the effect of
a MSK inhibitor SB-747651A [48] was also examined. In
agreement with the knockout data, SB-747651A was able to
inhibit IL-10 mRNA induction following stimulation of wild type
cells with zymosan (Fig 6D) but did not affect that ability of
zymosan to induce TNFa mRNA levels (Fig S2). In line with SB-
747651A acting on MSKs, it did not affect the residual stimulation
of IL-10 mRNA in MSK1/2 knockout cells (Fig 6D).
Together these results indicate that while MSKs contribute to
IL-10 transcription downstream of dectin-1, the effect of blocking
MSK activation on the initial stages of IL-10 transcription is
Figure 9. Zymosan induces the expression of regulatory macrophage markers. (A–H) Wild type BMDMs were stimulated with either
100 ng/ml LPS or 200 mg/ml zymosan for the indicated times. Total RNA was then isolated and the induction of SphK1 (A), LIGHT (B), IL-10 (C), IL-
12p40 (D), DUSP1 (E) or PTGS2 (F) mRNA determined by qPCR. In addition the levels of IL-10 (G) and IL-12p40 (H) protein secreted into the media
were measured at 8 h. Error bars represent the standard deviation of independent cultures from 4 mice.
doi:10.1371/journal.pone.0060086.g009
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different to blocking ERK1/2, an upstream activator of MSK1
and 2. To confirm that ERK1/2 could have an MSK independent
effect on IL-10 transcription, the effect of blocking ERK1/2
activation in MSK1/2 double knockout cells was examined. As in
wild type cells, in the MSK1/2 knockouts PD184352 was able to
increase zymosan induced IL-10 mRNA levels following 1 h of
stimulation (Fig 6E).
Other innate immune cells such as dendritic cells can also make
IL-10 in response to stimulation with zymosan. In agreement with
the effect of MSK1/2 knockout in BMDMs, MSK1/2 knockout
also reduced the secretion of IL-10 in BMDCs following
stimulation with either zymosan or curdlan (Fig 7A). A similar
result was also seen with CREB Ser133Ala knockin macrophages
(Fig 7B).
MSK knockout increases IL-12p40 induction in response
to zymosan
IL-10 is an anti-inflammatory cytokine and is able to repress the
induction of IL-12 by macrophages via a STAT3 dependent
mechanism [56]. Thus IL-10 secretion in response to PRR
activation is able to set an autocrine feedback loop on
macrophages that results in STAT3 phosphorylation. In line with
the decreased IL-10 production by MSK1/2 knockout cells
(Fig 5A), the phosphorylation of STAT3 on Tyr705 following
zymosan stimulation was lower in MSK1/2 knockout BMDMs
compared to wild type cells (Fig 8A). In response to zymosan
BMDMs produced only very small amounts of IL-12p70 (data not
shown), however they did produce measureable amounts of IL-
12p40. The secretion of IL-12p40, as well as the induction of IL-
12p40 mRNA, was increased in MSK1/2 knockout BMDMs
relative to wild type cells following zymosan stimulation (Fig 8B,
C). To confirm that IL-10 could repress the production of IL-
12p40 following zymosan stimulation BMDMs were prepared
from IL-10, MSK1/2 double knockout and MSK1/2/IL-10 triple
knockout cells. Relative to wild type cells, IL-10 knockout BMDMs
secreted more IL-12p40 in response to zymosan stimulation
(Fig 8D). MSK1/2 double knockout also increased IL-12p40
secretion, although not to the same extent as IL-10 knockout. This
may reflect the observation that the MSK1/2 knockout does not
completely abrogate IL-10 secretion or STAT3 phosphorylation in
response to zymosan stimulation (Fig 5, Fig 8A). No significant
difference was seen in IL-12p40 levels between IL-10 single and
MSK1/2/IL-10 triple knockout BMDMs, which would be
consistent with MSKs affecting IL-12p40 secretion via an IL-10
dependent mechanism.
Dectin-1 activation promotes regulatory markers in
BMDMs
The production of high levels of IL-10 but low levels of IL-12
have previously been shown to be a characteristic of regulatory or
M2b macrophages [57,58]. The induction of a regulatory like
phenotype in macrophages has been associated with greatly
increased expression of SphK1 and LIGHT mRNA [59]. LPS
stimulation was found to be a poor stimulus for the transcription of
either SphK1 or LIGHT. In contrast both SphK1 and LIGHT
mRNA levels were greatly increased in response to zymosan
(Fig 9A, B). This phenotype was also reflected in IL-10 mRNA
levels; while at 1 h LPS and zymosan induced similar levels of IL-
10 mRNA at later time points zymosan caused a higher and more
sustained induction of IL-10 mRNA (Fig 9C). These differences
were not reflected in all genes; for instance the induction of
DUSP1 and PTGS2 mRNAs were more comparable between the
two stimuli while LPS resulted in a much stronger induction of IL-
12p40 mRNA (Fig 9D–G). In line with the mRNA data, LPS
treatment resulted in more IL-12p40 secretion but less IL-10
secretion relative to zymosan (Fig 9G, H).
The upregulation of SphK1 and LIGHT was further examined.
The induction of both SphK1 and LIGHT was lower in dectin-1
knockout BMDMs relative to wild type cells (Fig 10), suggesting a
role for dectin-1 in promoting the maximal induction of these
genes. The inability of dectin-1 knockout to completely abolish the
induction of these two genes suggests that other receptors activated
by zymosan are involved in their regulation. In agreement with
this the dectin-1 specific agonist curdlan was much less effective at
promoting SphK1 and LIGHT mRNA induction (Fig 10). To
further analyze the pathways required for the induction of these
mRNAs, cells were pretreated with a Syk inhibitor before
stimulation with zymosan. Both the induction of SphK1 and
Figure 10. SphK1 and LIGHT mRNA induction is partially
regulated via dectin-1. BMDMs were isolated from either wild type
or dectin-1 mice on a C57/Bl6 background. Cells were stimulated with
either 200 mg/ml zymosan or 10 mg/ml curdlan for 8 h. Total RNA was
then isolated and SphK1 (A) and LIGHT (B) mRNA levels determined.
Error bars represent the standard deviation of independent cultures
from 4 mice per genotype. P values (Student’s t-test) of less than 0.01
are indicated by **.
doi:10.1371/journal.pone.0060086.g010
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LIGHT mRNA was decreased by the Syk inhibitor (Fig 11A, B).
The induction of these genes was also partially dependent on IL-
10, as the induction of both SphK1 and LIGHT was reduced, but
not abolished, by the knockout of IL-10 (Fig 11C, D). Finally we
examined the effect of MSK1/2 knockout on SphK1 and LIGHT
mRNA induction. At early time points following zymosan
stimulation there was a partial reduction in both SphK1 and
LIGHT mRNA induction in the MSK1/2 knockout BMDMs
relative to wild type macrophages, however this was not
maintained at later time points (Fig 11E, F).
Discussion
We show here that MSKs and CREB are directly involved in
regulating IL-10 transcription downstream of dectin-1. Stimula-
tion of macrophages with either dectin-1 specific ligands or the
combined dectin-1/TLR agonist zymosan stimulated CREB
phosphorylation. As discussed above, several kinases are able to
phosphorylate CREB on Ser133 in cells, however through the use
of MSK1/2 double knockouts we demonstrate that MSKs are the
major CREB kinases downstream of dectin-1. MSK1/2 knockout
or MSK1/2 inhibitors as well as mutation of the Ser133
phosphorylation site in CREB confirmed the importance of these
Figure 11. SphK1 and LIGHT mRNA induction is regulated by Syk and IL-10. (A, B) Wild type BMDMs were stimulated with 200 mg/ml
zymosan in the presence or absence of 4 mM Syk Inh II. The induction of SphK1 (A) and LIGHT (B) mRNA was determined by qPCR. (C, D) Wild type or
IL-10 knockout BMDMs were stimulated for 8 h with 200 mg/ml zymosan and the induction of SphK1 (C) and LIGHT (D) mRNA was determined by
qPCR. (E, F) Wild type or MSK1/2 knockout BMDMs were stimulated for 8 h with 200 mg/ml zymosan and the induction of SphK1 (E) and LIGHT (F)
mRNA was determined by qPCR. Error bars represent the standard deviation of independent cultures from 4 mice per genotype. P values (Student’s t-
test) of less than 0.05 are indicated by * and less than 0.01 by **.
doi:10.1371/journal.pone.0060086.g011
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proteins in regulating IL-10 transcription downstream of dectin-1.
This provides the first direct evidence for MSK activation and its
role in transcriptional regulation downstream of dectin-1.
In response to dectin-1, we show that both ERK1/2 and p38a
are able to phosphorylate and activate MSKs. The effects of small
molecule inhibitors of the ERK1/2 or p38a pathways did not
completely correspond to the effects of MSK1/2 knockout on IL-
10. When IL-10 secretion or IL-10 mRNA levels were measured
8 h after zymosan addition, an inhibition could be seen in the
presence of small molecule inhibitors of either the ERK1/2 or
p38a pathways, while a combination of both inhibitors had an
additive effect. This is in agreement with previous reports that
have shown that inhibition of ERK1/2 activation reduces IL-10
secretion in macrophages and dendritic cells [35,54]. Surprisingly
a different picture was seen at early time points when IL-10
mRNA induction was measured (Fig 3 and 4). At 1 h, blocking
ERK1/2 activation with the MEK1/2 inhibitor PD184352
promoted rather than inhibited IL-10 transcription. This was
independent of MSKs as it still occurred in MSK1/2 knockout
cells (Fig 6E). Thus at early time points ERK1/2 and p38 promote
IL-10 transcription via MSKs while ERK1/2 also inhibits IL-10
transcription via a distinct mechanism (Fig 12). Further work will
be required to determine the mechanism behind this ERK1/2
dependent inhibitory mechanism. Interestingly it is not the only
example of when ERK1/2 inhibition increasing cytokine tran-
scription. For example knockout of Tpl2, the MAP3K required for
ERK1/2 activation by TLRs, resulted in elevated INFb and IL-12
transcription in response to TLR4 and 9 agonists in macrophages
and conventional dendritic cells [60]. A similar effect on IL-12
induction was reported in double knockouts of p38c and d, due to
an unexpected requirement for these kinases to maintain Tpl2
protein levels in macrophages [61]. Significantly these effects were,
at least in part, independent of IL-10 as the MKK1/2 inhibitor
U0126 was still able to increase IFNb and IL-12 production in IL-
Figure 12. ERK1/2 regulate IL-10 transcription via MSK1/2 dependent and independent mechanisms. Dectin-1 is activated by complex
b-glucan containing particles that induce clustering of dectin-1 at the membrane and formation of a phagocytic synapse. This leads to Syk
recruitment to the ITAM like sequence in the cytoplasmic domain of dectin-1. Syk then mediates the activation of downstream signaling including
the ERK1/2 and p38aMAPK cascades. Both ERK1/2 and p38a phosphorylate and activate the protein kinases MSK1 and 2. These in turn phosphorylate
CREB on the IL-10 gene promoter, which stimulates IL-10 mRNA transcription. In addition, ERK1/2 also activate a MSK and p38 independent pathway
that inhibits IL-10 mRNA transcription. The identity of this pathway is not clear. In addition to the ERK1/2 and p38a pathways shown dectin-1 also
activates NFkB that likely also plays a role in inducing IL-10 transcription.
doi:10.1371/journal.pone.0060086.g012
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10 knockout cells [60]. The induction of c-fos by ERK1/2 was
proposed as a mechanism to explain the inhibition of IFNb and
IL-12 production by ERK1/2 [60]. In line with this, transgenic
overexpression of c-fos repressed TLR4 induced cytokine produc-
tion in dendritic cells [62]. Upregulation of c-fos may however not
explain the negative effects of ERK1/2 activity on IL-10
transcription as this paper demonstrated increased rather than
decreased IL-10 secretion in the c-fos transgenic mice. However as
these measurements were made at 6 or 24 hours after stimulation,
a transient early repressive effect of c-fos on IL-10 transcription
cannot be completely ruled out [62].
In vivo, macrophages have to play different roles depending on
their situation. This has led to the concept that different stimuli or
combinations of stimuli can polarize macrophages into distinct
phenotypes [57,58,63,64]. Relative to the TLR4 agonist LPS,
zymosan induced a high level of IL-10 production but a low level
of IL-12p40 (Fig 9). A similar cytokine profile has been linked to
‘regulatory’ or M2b polarized macrophages [59]. Regulatory
macrophages, while retaining the ability to produce some pro-
inflammatory cytokines have been suggested to limit inflammation
and promote resolution; for example they are able to improve
survival in mouse models of LPS induced endotoxic shock and
EAE [65,66,67]. In mice, SphK1 and LIGHT have been proposed
as markers for regulatory macrophages [59], and we found that
stimulation via dectin-1 in response to zymosan was able to induce
these genes (Fig 9). Regulatory macrophages were originally
described following co-stimulation of macrophages with LPS and
immune complexes, although other stimuli including apoptotic
neutrophils and PGE2 have also been described to induce a similar
phenotype in macrophages [58,68,69]. Interestingly both immune
complexes, via Fcc receptors, and dectin-1 can couple to
downstream signaling via the tyrosine kinase Syk [70,71]. Thus
zymosan, which acts via a combination of TLRs and dectin-1 may
activate similar signaling networks to those activated by a
combination of immune complexes and LPS. The induction of
both SphK1 and LIGHT was reinforced by an autocrine IL-10
feedback loop as demonstrated by the decreased induction of both
these genes in IL-10 knockout BMDMs (Fig 11). The decreased,
but not abolished, secretion of IL-10 in the MSK1/2 knockouts
(Fig 5) may therefore explain the transient decrease in SphK1 and
LIGHT mRNA induction in the MSK1/2 knockout macrophages
(Fig 11).
In summary we report here that MSKs play important roles in
regulating IL-10 production downstream of fungal PAMPS,
suggesting that MSKs could play a role in the control of fungal
infection. In addition, we provide evidence that in BMDMs
dectin-1 may stimulate an ERK1/2 pathway that transiently
antagonizes the action of IL-10.
Supporting Information
Figure S1 In vitro kinase selectivity of Syk Inhibitor II.
The effect of 0.1 or 1 mM Syk inhibitor II on the ability of a panel
of kinases to phosphorylate their substrates was determined.
Results are expressed as the % kinase activity remaining relative to
a control reaction with no inhibitor. Data is shown as the average
and variance of two measurements. The methods used in the
kinase selectivity screen are described in Bain et al, Biochemical
Journal, 2007, 408 (3); 297–315.
(PDF)
Figure S2 Effect of MAPK inhibitors and MSK1/2
knockout on TNF mRNA Induction. (A) Wild type BMDMs
were treated with 2 mM PD184352 or 5 mM SB203580 as
indicated. Cells were then stimulated for a further 1 h with
200 mg/ml zymosan. Total RNA was isolated and the levels of
TNF mRNA determined by qPCR. (B) as (A) except cells were
stimulated for 8 h with zymosan. (C) Wild type BMDMs were
incubated for 1 h with 5 mM SB-747651A before stimulation with
200 mg/ml zymosan for a further 1 h. TNF mRNA levels were
determined by qPCR. (D–F) Wild type or MSK1/2 knockout
BMDMs were stimulated for between 1 and 12 h as indicated with
either 200 mg/ml zymosan (D), 10 mg/ml curdlan (E) or 200 mg/
ml depleted zymosan (F). Error bars represent the standard
deviation of independent cultures from 4 mice per genotype.
(PDF)
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